Advancing Desmoid Tumor Science
DTRF funds innovative research on desmoid tumors, prioritizing projects that explore disease biology, novel therapies, and translational approaches to improve understanding and treatment.
Funder: Desmoid Tumor Research Foundation
Due Dates (Anticipated): March 2027 (Letter of Intent) | April 2027 (Full Application)
Funding Amounts: Up to $65,000/year for 1–3 years (standard grants); up to $30,000/year for 1 year (pilot grants); no indirect costs allowed.
Summary: Supports innovative research advancing the understanding, prevention, diagnosis, and treatment of desmoid tumors, with an emphasis on translational and cross-disciplinary projects.
Key Information: Indirect costs are not permitted; applicants must have an MD/PhD (or equivalent) and be at Assistant Professor rank or higher.
Description
The Desmoid Tumor Research Foundation (DTRF) funds research projects that seek to advance scientific knowledge about desmoid tumors, with the ultimate goal of developing new treatments and finding a cure. The program is open to investigator-initiated proposals spanning basic, translational, clinical, and computational research. Special priority is given to projects exploring spontaneous regression, disease stabilization, and novel therapeutic approaches. Cross-disciplinary collaborations and proposals with clear translational relevance are strongly encouraged. Both established and early-stage investigators are welcome to apply, and innovative pilot projects are supported.
